ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013

DeVita Will Ask NTP To Return Some NCI Funs To help Cover Shortfall In Center Core Budget

January 18, 1980

NY Federal Court Rules Against Myriad, Finding Patents On Genes Unlawful.

April 2, 2010

In Brief: Gerald Dodd, Walter Lawrence Head ACS; Reauthorization Bills Expected Early ‘91

November 16, 1990

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999